Abstract
Although polymeric nanoconjugates (NCs) hold great promise for the treatment of cancer patients, their clinical utility has been hindered by the lack of efficient delivery of therapeutics to targeted tumor sites. Here, we describe an albumin-functionalized polymeric NC (Alb-NC) capable of crossing the endothelium barrier through a caveolae-mediated transcytosis pathway to better target cancer. The Alb-NC is prepared by nanoprecipitation of doxorubicin (Doxo) conjugates of poly(phenyl O-carboxyanhydrides) bearing aromatic albumin-binding domains followed by subsequent surface decoration of albumin. The administration of Alb-NCs into mice bearing MCF-7 human breast cancer xenografts with limited tumor vascular permeability resulted in markedly increased tumor accumulation and anti-tumor efficacy compared to their conventional counterpart PEGylated NCs (PEG-NCs). The Alb-NC provides a simple, low-cost and broadly applicable strategy to improve the cancer targeting efficiency and therapeutic effectiveness of polymeric nanomedicine.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1189-1200 |
| Number of pages | 12 |
| Journal | Biomaterials Science |
| Volume | 6 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2018 |
Fingerprint
ASJC Scopus subject areas
- Biomedical Engineering
- Materials Science(all)
Cite this
Albumin as a "trojan Horse" for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting. / Yin, Qian; Tang, Li; Cai, Kaimin; Yang, Xujuan; Yin, Lichen; Zhang, Yanfeng; Dobrucki, Lawrence W.; Helferich, William G.; Fan, Timothy M.; Cheng, Jianjun.
In: Biomaterials Science, Vol. 6, No. 5, 05.2018, p. 1189-1200.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Albumin as a "trojan Horse" for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting
AU - Yin, Qian
AU - Tang, Li
AU - Cai, Kaimin
AU - Yang, Xujuan
AU - Yin, Lichen
AU - Zhang, Yanfeng
AU - Dobrucki, Lawrence W.
AU - Helferich, William G.
AU - Fan, Timothy M.
AU - Cheng, Jianjun
PY - 2018/5
Y1 - 2018/5
N2 - Although polymeric nanoconjugates (NCs) hold great promise for the treatment of cancer patients, their clinical utility has been hindered by the lack of efficient delivery of therapeutics to targeted tumor sites. Here, we describe an albumin-functionalized polymeric NC (Alb-NC) capable of crossing the endothelium barrier through a caveolae-mediated transcytosis pathway to better target cancer. The Alb-NC is prepared by nanoprecipitation of doxorubicin (Doxo) conjugates of poly(phenyl O-carboxyanhydrides) bearing aromatic albumin-binding domains followed by subsequent surface decoration of albumin. The administration of Alb-NCs into mice bearing MCF-7 human breast cancer xenografts with limited tumor vascular permeability resulted in markedly increased tumor accumulation and anti-tumor efficacy compared to their conventional counterpart PEGylated NCs (PEG-NCs). The Alb-NC provides a simple, low-cost and broadly applicable strategy to improve the cancer targeting efficiency and therapeutic effectiveness of polymeric nanomedicine.
AB - Although polymeric nanoconjugates (NCs) hold great promise for the treatment of cancer patients, their clinical utility has been hindered by the lack of efficient delivery of therapeutics to targeted tumor sites. Here, we describe an albumin-functionalized polymeric NC (Alb-NC) capable of crossing the endothelium barrier through a caveolae-mediated transcytosis pathway to better target cancer. The Alb-NC is prepared by nanoprecipitation of doxorubicin (Doxo) conjugates of poly(phenyl O-carboxyanhydrides) bearing aromatic albumin-binding domains followed by subsequent surface decoration of albumin. The administration of Alb-NCs into mice bearing MCF-7 human breast cancer xenografts with limited tumor vascular permeability resulted in markedly increased tumor accumulation and anti-tumor efficacy compared to their conventional counterpart PEGylated NCs (PEG-NCs). The Alb-NC provides a simple, low-cost and broadly applicable strategy to improve the cancer targeting efficiency and therapeutic effectiveness of polymeric nanomedicine.
UR - http://www.scopus.com/inward/record.url?scp=85046296256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046296256&partnerID=8YFLogxK
U2 - 10.1039/c8bm00149a
DO - 10.1039/c8bm00149a
M3 - Article
C2 - 29570190
AN - SCOPUS:85046296256
VL - 6
SP - 1189
EP - 1200
JO - Biomaterials Science
JF - Biomaterials Science
SN - 2047-4830
IS - 5
ER -